Healthcare provider profile · identity verified

Tracy C Mckay, D.O.

Family Practice · DADE CITY, FL · NPI 1851323265

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Tramadol Hcl	Tramadol Hcl	379	77
Rosuvastatin Calcium	Rosuvastatin Calcium	202	64
Atorvastatin Calcium	Atorvastatin Calcium	194	68
Alprazolam	Alprazolam	159	27
Tamsulosin Hcl	Tamsulosin Hcl	153	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	152	27
Lisinopril	Lisinopril	132	42
Losartan Potassium	Losartan Potassium	132	47
Amlodipine Besylate	Amlodipine Besylate	125	41
Pantoprazole Sodium	Pantoprazole Sodium	119	34
Gabapentin	Gabapentin	117	39
Omeprazole	Omeprazole	111	31
Levothyroxine Sodium	Levothyroxine Sodium	103	26
Metformin Hcl	Metformin Hcl	92	29
Simvastatin	Simvastatin	84	25
Allopurinol	Allopurinol	73	19
Carvedilol	Carvedilol	73	25
Zolpidem Tartrate	Zolpidem Tartrate	73	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	70	18
Lorazepam	Lorazepam	68	12
Meloxicam	Meloxicam	61	14
Furosemide	Furosemide	58	21
Metoprolol Tartrate	Metoprolol Tartrate	58	17
Citalopram Hbr	Citalopram Hydrobromide	56	16
Sildenafil Citrate	Sildenafil Citrate	56	14
Trazodone Hcl	Trazodone Hcl	50	18
Clopidogrel	Clopidogrel Bisulfate	48	16
Wixela Inhub	Fluticasone Propion/Salmeterol	47	suppressed
Celecoxib	Celecoxib	46	suppressed
Glipizide	Glipizide	42	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	40	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	38	13
Montelukast Sodium	Montelukast Sodium	38	13
Atenolol	Atenolol	37	12
Baclofen	Baclofen	37	11
Potassium Chloride	Potassium Chloride	37	13
Glipizide Er	Glipizide	36	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	36	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	suppressed
Famotidine	Famotidine	33	11
Metformin Hcl Er	Metformin Hcl	32	suppressed
Sertraline Hcl	Sertraline Hcl	32	12
Metoprolol Succinate	Metoprolol Succinate	29	11
Mounjaro	Tirzepatide	29	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Eliquis	Apixaban	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Finasteride	Finasteride	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Azithromycin	Azithromycin	14	14
Levetiracetam	Levetiracetam	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Novolin R	Insulin Regular, Human	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Temazepam	Temazepam	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Primidone	Primidone	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Ozempic	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error